Need for high investment, lack of necessary facilities and the complex nature of the virus make the finding of a vaccine for Ebola a difficult challenge, a noted French microbiologist said here today. "Developing a vaccine is not a trivial issue. It requires huge investments by pharmaceutical companies. So far, Ebola has had limited outbreaks. So there was no need for the community to be convinced that there has to be a vaccine.